US Broker Ratings

MeiraGTx Holdings plc (MGTX) Stock Analysis: A 248% Potential Upside with Promising Gene Therapy Innovations

In the bustling world of biotechnology, MeiraGTx Holdings plc (NASDAQ: MGTX) is carving out a niche with its cutting-edge gene therapy solutions. With a market cap..

Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Navigating a Challenging Market with 36.94% Potential Upside

Cross Country Healthcare, Inc. (NASDAQ: CCRN) stands as a prominent player in the healthcare sector, specifically within the medical care facilities industry. Headquartered in Boca Raton,..

Myriad Genetics, Inc. (MYGN) Stock Analysis: Exploring a 26.50% Potential Upside Amidst Healthcare Diagnostics Growth

Investors with a keen eye on the healthcare sector might find Myriad Genetics, Inc. (NASDAQ: MYGN) an intriguing prospect. Known for its innovative footprint in molecular..

Emergent BioSolutions Inc. (EBS) Stock Analysis: Exploring the 44.85% Potential Upside for Investors

Emergent BioSolutions Inc. (NYSE: EBS), a key player in the healthcare sector specializing in preparedness and response solutions for public health threats, presents a compelling opportunity..

Cel-Sci Corporation (CVM) Stock Report: Unpacking the 3,171% Potential Upside

For those with a keen interest in the biotechnology sector, Cel-Sci Corporation (NASDAQ: CVM) offers an intriguing narrative. This clinical-stage biotech company, valued at a market..

Personalis, Inc. (PSNL) Stock Analysis: Exploring a 51.56% Potential Upside in the Diagnostics & Research Sector

For investors with an eye on the healthcare sector, Personalis, Inc. (NASDAQ: PSNL) offers a fascinating prospect with its innovative approach in the diagnostics and research..

Sana Biotechnology, Inc. (SANA) Stock Analysis: Unpacking a 140% Potential Upside in the Biotech Frontier

Sana Biotechnology, Inc. (NASDAQ: SANA) is capturing the attention of investors with its promising potential upside of 140.74%. This Seattle-based biotech company is carving out a..

Verve Therapeutics, Inc. (VERV) Stock Analysis: Unveiling a Potential 17.92% Upside in the Gene Editing Arena

Verve Therapeutics, Inc. (NASDAQ: VERV) is making waves in the biotechnology sector with its pioneering approach to treating cardiovascular diseases through gene editing. Based in Boston,..

REGENXBIO Inc. (RGNX) Stock Analysis: A Biotech Innovator with a Potential 266.83% Upside

REGENXBIO Inc. (NASDAQ: RGNX), a clinical-stage biotechnology company, has captured investor attention with its cutting-edge gene therapy pipeline and a staggering potential upside of 266.83%. Despite..

Organogenesis Holdings Inc. (ORGO) Stock Analysis: Exploring a Promising 78.97% Potential Upside

Investors eyeing opportunities in the healthcare sector should take a closer look at Organogenesis Holdings Inc. (NASDAQ: ORGO), a company that stands at the forefront of..

Bioventus Inc. (BVS) Stock Analysis: Exploring an 80% Upside Potential in the Medical Device Arena

Bioventus Inc. (NASDAQ: BVS), a prominent player in the healthcare sector specializing in medical devices, stands at the intersection of innovation and potential growth. Headquartered in..

Theravance Biopharma, Inc. (TBPH) Stock Analysis: Unveiling a 34.7% Potential Upside for Investors

Theravance Biopharma, Inc. (NASDAQ: TBPH) is making waves in the biotechnology sector with its promising pipeline and strategic collaborations. Based in South San Francisco, California, this..

Celcuity Inc. (CELC) Stock Analysis: Promising Upside Potential of 37.81% with Robust Buy Ratings

Celcuity Inc. (NASDAQ: CELC), a clinical-stage biotechnology company based in Minneapolis, Minnesota, is emerging as a compelling investment opportunity within the healthcare sector. With a market..

Prothena Corporation plc (PRTA) Stock Analysis: Exploring a 203.74% Potential Upside in Biotechnology

Prothena Corporation plc (NASDAQ: PRTA) is making waves in the biotechnology sector, drawing investor attention with a notable 203.74% potential upside based on average analyst target..

Eton Pharmaceuticals, Inc. (ETON) Stock Analysis: Uncovering a 75% Upside Potential in the Specialty Drug Market

Eton Pharmaceuticals, Inc. (ETON) is capturing significant attention from investors with a remarkable 75.54% potential upside, according to analyst ratings. Operating in the healthcare sector and..

Cullinan Therapeutics (CGEM) Stock Analysis: A Biotech Play with a 241.88% Upside Potential

For investors with a keen interest in the biotechnology sector, Cullinan Therapeutics, Inc. (NASDAQ: CGEM) presents an intriguing opportunity. This clinical-stage biopharmaceutical company, headquartered in Cambridge,..

Community Health Systems, Inc. (CYH) Stock Analysis: Navigating Through Potential 30.82% Upside

Community Health Systems, Inc. (NYSE: CYH), a notable player in the healthcare sector, has captured investor attention with a potential upside of 30.82%. As the company..

Sionna Therapeutics, Inc. (SION) Stock Analysis: A 62% Upside Potential in the Cystic Fibrosis Market

Sionna Therapeutics, Inc. (NASDAQ: SION) is making waves in the biotechnology sector with its focus on innovative treatments for cystic fibrosis (CF). With a market capitalization..

Opthea Limited (OPT) Stock Analysis: Navigating Biotech’s Uncertain Waters with a -60.90% Potential Downside

Opthea Limited (ASX: OPT) is a clinical-stage biopharmaceutical company that has garnered significant attention in the biotechnology sector, particularly for its pioneering work in developing treatments..

Kamada Ltd. (KMDA) Stock Analysis: Unpacking a Promising 98.72% Potential Upside

For investors keeping an eye on the healthcare sector, Kamada Ltd. (NASDAQ: KMDA) offers a compelling opportunity, especially given its robust potential upside of 98.72%. Specializing..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds